SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-039427
Filing Date
2021-07-30
Accepted
2021-07-30 09:15:27
Documents
2
Period of Report
2021-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea144956-8k_virpaxpharma.htm 8-K 20852
2 PRESS RELEASE, DATED JULY 30, 2021, ISSUED BY VIRPAX PHARMACEUTICAL, INC. ea144956ex99-1_virpaxpharma.htm EX-99.1 13467
  Complete submission text file 0001213900-21-039427.txt   35627
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 211130339
SIC: 2834 Pharmaceutical Preparations